Scott A. Holmes, Chief Financial Officer at KERYX BIOPHARMACEUTICALS INC (KERX), bought 5,000 shares at $5.72 ($29K) on 2015-08-21, disclosed to the SEC on 2015-08-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| KERX | SELL | 2018-08-16 | $4K | — | Filing → |
| KERX | SELL | 2018-07-31 | $9K | — | Filing → |
| KERX | SELL | 2018-05-16 | $7K | — | Filing → |